PHARMACEUTICAL CARE IN GERIATRIC PATIENTS: OPTIMIZING MEDICATION USE AND OUTCOMES
Main Article Content
Keywords
pharmaceutical care, geriatric patients, medication use, outcomes, polypharmacy
Abstract
Pharmaceutical care in geriatric patients is crucial to optimizing medication use and outcomes in this vulnerable population. This essay explores the importance of providing tailored pharmaceutical care to geriatric patients to address age-related changes in physiology, pharmacokinetics and pharmacodynamics, as well as multiple comorbidities and polypharmacy. The essay discusses the methods used to optimize medication use in geriatric patients, the challenges faced in providing pharmaceutical care to this population, and the outcomes of proper medication management. By emphasizing the role of the pharmacist in geriatric care, this essay highlights the significance of holistic pharmaceutical care in improving the quality of life and health outcomes of elderly patients.
References
2. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007; 370:185-91.
3. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007; 5(4):345-351.
4. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised?. The Lancet. 2007;370(9582):173-184.
5. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database of Systematic Reviews. 2012(5).
6. Alldred DP, Raynor DK, Hughes C, Barber N, Chen TF, Spoor P. Interventions to optimise prescribing for older people in care homes. Cochrane Database of Systematic Reviews. 2013(2).
7. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989-995.
8. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6-14.
9. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-37.
10. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187-195.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Faisal Ibrahim Mohammad Alwaddani
Pharmacist, Althager Hospital
Majed Ali Mohammed Alghamdi
Pharmacy technician, Althager hospital
Walid Salim Almutairi
Pharmacy technician, Al-Thaghr Hospital
Faris Saud Hassan Almutairi
Pharmacist Assistant, Althager hospital
Amin Mohammed Aljedaani
Pharmacy technician, Iradah and mental health complex - mental services- Jeddah
Shaher Mohammed aljedaani
Pharmacist, King Abdulaziz International Airport
